Microsporidia are obligate intracellular, spore-forming, fungal-related pathogens that employ a unique organelle, the polar tube, to transfer infectious spore contents into host cells to initiate infection. Spore adherence to host cells may provide the proximity required for polar tube/host cell interaction during in vivo infection. In previous in vitro studies, host sulfated glycosaminoglycans (GAGs) or recombinant microsporidia endospore protein (EnP1) was implicated in the pathogen adherence and infection process; however, complete ablation of spore adherence and infection could not be achieved, suggesting that additional or alternative spore and host cell determinants of adherence and infection may exist. Analysis of the Encephalitozoon intestinalis genome revealed about 100 predicted proteins containing the canonical integrin-binding motif arginine-glycine-aspartic acid (RGD); and, many pathogens have been shown to engage integrin molecules on cell surfaces. We hypothesized that host cell integrins play a role in microsporidia adherence and infection. In this study, we demonstrated that addition of exogenous integrin ligands or recombinant alpha 3 beta 1 integrin or alpha 5 beta 1 integrin to assays of E. intestinalis adherence and infection significantly reduced spore adherence and infection of host cells, supporting our hypothesis and implicating these specific integrins as putative host cell receptors for E. intestinalis spores.
INTRODUCTION
Microsporidia are obligate intracellular, spore-forming, fungalrelated pathogens that infect a wide range of invertebrate and vertebrate animals. Of the microsporidia known to infect humans, Enterocytozoon bieneusi and Encephalitozoon intestinalis are most commonly associated with human disease (Didier 2005) . Immunocompromised individuals can exhibit severe manifestations of microsporidiosis including chronic diarrhea, malabsorption, wasting, disseminated disease and death (Conteas et al. 1998; Garcia 2002; Coyle et al. 2004; Stark et al. 2009 ).
Immunocompetent individuals may also be infected but show only mild or no symptoms, suggesting that human exposure and retention of microsporidia may be relatively common (Hautvast et al. 1997; Kucerova-Pospisilova et al. 2003; Sak et al. 2011) . Currently available therapies for human microsporidiosis are limited, and understanding the mechanisms of the infectious process will facilitate the development of safe and effective treatments for microsporidia infection.
Microsporidia are usually transmitted to humans by the fecal-oral route upon the ingestion of contaminated water (Stark et al. 2009) ; given this route of infection, the initial site of infection in humans is usually the epithelium of small intestine (Orenstein et al. 1990) . The specific mechanism(s) of spore activation, which involves polar tube extrusion, is unknown. Nonetheless, the everted polar tube may either pierce the host cell or be taken into the cell by cellular membrane invagination (Xu et al. 2004; Bohne, Böttcher and Gross 2011) . Alternatively, spores may be phagocytosed with subsequent extrusion of the polar tube occurring from within host cells allowing for the escape of phagocytosis (Franzen 2004; Bohne, Böttcher and Gross 2011) . Upon infection, the sporoplasm passes through the polar tube into the cytoplasm where new spores progress through multiple developmental stages before the host cells rupture to release mature spores.
Spores adhere tightly to host cell surfaces in vitro and cannot be removed by repeated washing. During in vivo infection, spore adherence to host cells may ensure the necessary proximity for polar tube/host cell interaction and the transfer of sporoplasm into host cells. Determination of host cell and spore components that participate in adherence has helped clarify the role that spore adherence plays in microsporidia infection of host cells in vitro. Previously, we have shown that in vitro spore adherence to host cells was significantly reduced by the presence of exogenous sulfated glycosaminoglycans (GAGs) to spore adherence assays (Hayman, Southern and Nash 2005) . We have also shown that the microsporidia spore surface protein EnP1 binds to host cells and that the addition of exogenous recombinant EnP1 or EnP1 antibodies to spore adherence assays significantly inhibited spore adherence (Southern et al. 2007 ). Importantly, both these studies demonstrated that decreased spore adherence to host cells resulted in subsequent reduction in infection. These data helped shape our hypothesis that spore adherence is a critical part of microsporidia infection of host cells. However, complete ablation of spore adherence and infection was not achieved in these previous studies, suggesting that additional or alternative spore and host cell determinants of adherence and infection may exist.
Many pathogenic microbes including viruses, bacteria and parasites adhere to mammalian cell surface GAGs, extracellular matrix (ECM) proteins and ECM-binding integrins as a means for invasion of host cells, for spreading to neighboring cells, and for dissemination within the host (Patti et al. 1994; Finlay and Falkow 1997; Rostand and Esko 1997; Bartlett and Park 2010) . Integrins are heterodimeric, transmembrane proteins which, through their interactions with ECM and cytosolic components, carry out crucial functions in cell structure, development, adhesion, migration and signaling (Benoit et al. 2012) . Often, the ECM protein-binding motif that interacts with integrins involves the amino acids arginine-glycine-aspartic acid (RGD), although other motifs are known (D'Souza, Ginsberg and Plow 1991) . In this study, we hypothesize that host cell integrins are involved in microsporidia adherence to and infection of host cells and that the addition of exogenous integrins or integrin ligands to in vitro adherence and infection assays will inhibit spore adherence/infection.
MATERIALS AND METHODS

Host cell and microsporidia cultivation
Adherent African green monkey kidney cells (Vero; ATCC CCL-81) were used for spore cultivation and experiments. The cell lines were cultivated as previously described (D'Souza, Ginsberg and Plow 1991) at 37
• C and 5% CO 2 in culture medium consisting of Dulbecco's Modified Eagle's Medium (BioWhittaker, Walkersville, MD) supplemented with 2 mM L-glutamine, 100U ml −1 penicillin, 100U ml −1 streptomycin, 0.25 mcg (microgram) ml −1 amphotericin B and 10% fetal bovine serum (FBS). Vero cells were maintained in the above culture media with 2% FBS. Encephalitozoon intestinalis spores were propagated in Vero cells as previously described (Hayman and Nash 1999) .
Spore adherence assay
Spore adherence assays were performed as previously described (Hayman, Southern and Nash 2005) , with the addition of exogenous protein or antibodies to the assay as putative inhibitors of spore adherence. Host cells were seeded onto 18 mm 2 glass coverslips, at 1 × 10 5 cells per well density, in 12-well plates with 2% FBS-supplemented culture media and grown to ∼95% confluence. To measure spore adherence, the 12-well plates containing the coverslips with Vero monolayers were incubated on ice for 30 min. The culture medium was then aspirated from the 12-well plates, and 10 7 spores in 1 mM MnCl 2 -supplemented culture media was added per well to the plates. In previous work, the divalent cation MnCl 2 was shown to augment spore adherence as much as 6-fold (Southern, Jolly and Hayman 2006) . It is speculated that the divalent cations are activating either a spore ligand or host cell receptor, possibly integrins (Xiong et al. 2003) . The 12-well plates were incubated on ice (to minimize host cell surface protein turnover) for 4 h, and coverslips were washed with 1X phosphate buffer pH 7.4 (PBS) to remove unbound spores.
The host cell monolayers with attached spores were fixed with a 1:1 solution of acetone:methanol for 10 min at room temperature, washed by covering with PBS for 5 min, stained with 0.01% Uvitex 2B (Polysciences, Inc., Warrington, PA) for 10 min, washed with PBS for 5 min, counterstained with 1 mcg ml −1 4 ,6-diamidino-2-phenylindole, dichloride (DAPI) (Life Technologies Corporation, Carlsbad, CA) for 5 min, washed with PBS for 5 min and inverted onto VECTASHIELD mounting medium (Vector Laboratories, Burlingame, CA) on microscope slides. The number of attached spores and host cell nuclei were counted at ×630 (oil immersion) magnification with an ultraviolet filter using an Olympus BH-2 fluorescent microscope. Results for adherence assays are expressed as the percentage of adherent spores relative to control samples. To evaluate the effect of exogenous integrin ligands on spore adherence to Vero cells, the ECM proteins collagen (Southern Biotech, Birmingham, AL), laminin (BD Biosciences, San Jose, CA), fibronectin (Sigma-Aldrich, St. Louis, MO) and vitronectin (Sigma-Aldrich), the control protein bovine serum albumin (Sigma-Aldrich), or cyclical RGD or RAD peptides (cyclo (Arg-Gly-Asp-D-Phe-Val) and cyclo (Arg-Ala-Asp-D-Phe-Val), respectively; Peptides International, Louisville, KY) were diluted in PBS (0.0001 to 10 mcg ml −1 concentrations) and preincubated with the host cells on ice for 1 h before spore adherence assays were performed. The effect of anti-integrin antibodies on spore adherence to Vero cells was evaluated by preincubation of the cells (1 h, on ice) with antibodies to alpha 1-6, alpha V or beta 1-5 integrin chains (Millipore, Billerica, MA) diluted in 2% FBS-supplemented culture medium to 5 or 20 mcg ml −1 final concentration. After pretreatment, the medium with antibodies was aspirated from the cells, and spores in MnCl 2 -supplemented culture medium were incubated on the cells as described above. The effect of exogenous recombinant human integrins on spore adherence to Vero cells was evaluated by including 5 or 20 mcg ml −1 final concentration PBS-diluted recombinant alpha 3 beta 1 integrin, alpha 5 beta1 integrin, alpha 6 beta 4 integrin (R&D Systems, Minneapolis, MN) or PBS alone, as a control, in the spores/MnCl 2 -supplemented culture medium for adherence assays as described above. The Vero cells for the recombinant integrin spore adherence assays were not preincubated prior to spore incubation on the cells.
Host cell infection assay
Following the adherence assay, the unbound spores were removed by PBS washing, the coverslips were placed into new 12-well plates with fresh culture medium and incubated with 5% CO 2 at 37
• C for ∼30 h to allow the attached spores to infect the host cells. Following incubation for infection, fixing, staining and counterstaining were performed as described for adherence assays. The number of infectious foci and host cell nuclei were counted at ×630 (oil immersion) magnification with an ultraviolet filter. Results for infection assays are expressed as percentage of host cell infection (infectious foci per nucleus) relative to control samples.
Statistical analysis
For each adherence and infection assay, a single coverslip seeded Vero cells was generated per experimental condition and 20 microscopic fields were evaluated per coverslip. All experiments were performed three times with similar results.
Representative individual experiments, of the three independent experiments performed, are shown. Statistically significant difference from controls was determined using the Student's t test. P values of <0.05 are considered statistically significant ( * ), and P values of <0.0001 are indicated ( * * ). Error bars represent standard deviation.
RESULTS
Exogenous ECM proteins inhibit microsporidia spore adherence and host cell infection
Previous studies indicate that up to 85% of microsporidia spore adherence to host cells can be inhibited by the addition of sulfated GAGs in a spore adherence assay, leaving 15% of spores adherent to host cells to produce host cell infection under these conditions (Hayman, Southern and Nash 2005) . This suggests that the mechanism mediated by sulfated GAGs is not the only mechanism of adherence that microsporidia employ in the infection process. Therefore, a spore adherence and infection assay developed in our lab was used to evaluate the possible role of integrins in Encephalitozoon intestinalis adherence to Vero host cells (an adherent African green monkey-derived cell line) (see Fig. S1 in supplemental data). The ECM proteins used as potential inhibitors of spore adherence included collagen, laminin, fibronectin and vitronectin, which all have been shown to bind integrins directly (Kupiec-Weglinski et al. 1993) . Host cell preincubation with 1 mcg ml −1 collagen, laminin, fibronectin or vitronectin prior to addition of E. intestinalis spores significantly inhibited spore adherence to host cells by ∼35% of control adherence (Fig. 1A) . When cells preincubated with these ECMs and inoculated with E. intestinalis spores were further incubated to allow infection, host cell infection was also significantly reduced by ∼30% of control infection (Fig. 1B) . Preincubation of cells with serial dilutions of ECMs demonstrated a trend toward decreasing spore adherence with increasing ECM protein concentration of ECM proteins (Fig. 2) . Preincubation of cells with higher concentrations of ECM proteins (up to 10 mcg ml −1 ) did not further inhibit adherence or infection (data not shown).
Combination of ECM proteins does not further inhibit spore adherence and infection
The approximately equivalent inhibition of E. intestinalis adherence to and infection of host cells (∼35% and ∼30%, respectively; Fig. 1A and B) by 1 mcg ml −1 of the individual ECM proteins suggested that these proteins might be operating via a common mechanism to elicit the observed effect on spore adherence/infection. To determine if the ECM proteins act via a common mechanism or discrete mechanisms, a combination of ECM proteins was preincubated with cells prior to assays of adherence and infection. Preincubation of cells with a combination of collagen, laminin, fibronectin and vitronectin (1 mcg ml −1 each; 4 mcg ml −1 total ECM proteins) significantly inhibited subsequent E. intestinalis adherence to and infection of host cells by ∼40% and ∼30%, respectively ( Fig. 3A and B) . The failure of multiple, combined ECM proteins to inhibit spore adherence and infection to a greater extent than the individual ECM proteins alone suggests that these proteins may act with redundancy via a common mechanism.
Preincubation of cells with ECM proteins prior to GAG-dependent inhibition of adherence and infection does not further decrease adherence or infection
To determine if ECM preincubation has an effect on sulfated GAG-dependent inhibition of adherence and infection, cells were preincubated with combined ECM proteins prior to assays of E. intestinalis adherence carried out in the presence of the exogenous sulfated GAG chondroitin sulfate A (CSA). The concomitant addition of 10 mg ml −1 CSA with addition of spores to host cells significantly inhibited adherence by ∼60% of control adherence and significantly inhibited host cell infection by ∼40% of control infection ( Fig. 3A and B) . Preincubation of cells with combined ECM proteins prior to the spore adherence and infection assays with CSA did not increase inhibition of adherence or infection of host cells compared to control preincubation alone prior to the addition of spores and CSA ( Fig. 3A and B) . These data suggest that the known sulfated GAG-mediated spore interaction with host cells and the ECM-mediated effect on spore adherence and infection demonstrated in this study may exert their effects via a single perhaps complex and multicomponent mechanism.
Asparagine-glycine-aspartic acid (RGD)-containing peptides inhibit spore adherence and host cell infection
Short RGD-containing peptides can inhibit cell adherence to collagen, laminin, fibronectin or vitronectin-coated culture plates (Verrier et al. 2002) and interact directly with integrins (Hay 1991) . Because all of the evaluated ECMs contain the canonical integrin-binding RGD amino acid sequence (D'Souza, Ginsberg and Plow 1991) and about 100 predicted E. intestinalis proteins contain this sequence (see Table S1 in Supplemental Data), the interaction of a putative RGD-sequence-containing E. intestinalis protein with a host cell surface moiety is plausible. To determine if the RGD sequence alone can modulate spore adherence to host cells, cells were preincubated with a short RGDcontaining peptide prior to assays of E. intestinalis adherence and infection. Host cell preincubation with the RGD peptide, but not a control RAD peptide, significantly inhibited spore adherence to host cells with ∼40% inhibition of control adherence at 10 mcg ml −1 peptide concentration (Fig. 4A ). Cells preincubated with the RGD or RAD peptides were also assayed for infection. Host cell infection was significantly reduced by ∼20% of control infection with 10 mcg ml −1 RGD preincubation, while RAD preincubation had no effect on infection (Fig. 4B) . In vitro inhibition of E. intestinalis adherence and infection of cells by preincubation of the cells with known ligands, including both ECM protein ligands and the RGD peptide, supports our hypothesis that integrins are involved in microsporidia adherence to and infection of host cells. 
Specific integrin antibodies and recombinant integrins inhibit spore adherence and host cell infection
The ECM proteins used in this study can directly interact not only with integrins, but also with other protein and carbohydrate components of the ECM (Hay 1991) . Thus, the inhibition of spore adherence and infection by the addition of exogenous integrin-binding partners to adherence/infection assays suggests that host cell integrins are involved in spore adherence in vitro but do not demonstrate that the exogenous ligands are interacting directly with integrins to exert the observed effects. However, data generated using commercially available alpha and beta integrin-mediated cell adhesion arrays (Chemicon (Millipore), per manufacturer's instructions) indicated that the Vero cells used for spore adherence and infection assays in this study consistently bound anti-alpha 3, alpha 5, beta 1 or beta 2 integrin chain antibody-coated microplate wells. The Vero cells variably and poorly bound anti-alpha 4 integrin chain antibodycoated wells, and did not bind wells coated with other antiintegrin chain antibodies including anti-alpha 1, alpha 2, alpha V, beta 3 and beta 5 (anti-alpha 6 was not evaluated; data not shown). This indicates that alpha 3, alpha 5, beta 1, beta 2 and possibly beta 4 integrin chains are expressed on the host cells used in our assays.
To examine the possible role of host cell integrins in spore adherence and infection more directly, Vero host cells were preincubated with 5 or 20 mcg ml −1 commercially available (Chemicon (Millipore)) monoclonal, function blocking antibodies against human alpha 1-6, alpha V or beta 1-5 integrin chains prior to assays of E. intestinalis adherence and infection. Preincubation with 20 mcg ml −1 anti-alpha 3, alpha 5, beta 1 or beta 2 integrin chain antibodies, but not the remaining antibodies, significantly inhibited spore adherence to host cells by ∼30% of control adherence (Fig. 5A) . Adherence assays performed after similar preincubation of host cells with 5 mcg ml −1 antiintegrin chain antibodies showed similar results without significantly less inhibition of adherence (data not shown). Host cell preincubation with antibodies against alpha 3, alpha 5, beta 1 and beta 2 integrin chains also significantly inhibited infection of host cells by ∼20% of control infection, while the remaining anti-integrin chain antibodies had no effect on infection (Fig. 5B) . The inhibition of spore adherence/infection of host cells by specific anti-integrin chain antibodies provides further, more direct support for our hypothesis that host cell integrins are involved in microsporidia adherence to and infection of host cells. Assays were conducted to determine if the addition of exogenous recombinant human alpha 3 beta 1, alpha 5 beta 1 or alpha 6 beta 4 integrins concomitantly with E. intestinalis spores during adherence/infection assays may modulate spore adherence to and/or infection of host cells. The addition of alpha 3 beta 1 or alpha 5 beta 1 integrins to adherence assays significantly inhibited spore adherence by ∼60% of control adherence (Fig. 6A) and similarly inhibited host cell infection by ∼60% of control infection (Fig. 6B) . The addition of alpha 6 beta 4 integrin to the described assays had no effect on spore adherence to or infection of host cells. This was expected based on previously performed alpha and beta integrin-mediated cell adhesion arrays that shows that alpha 6 beta 4 chains are not expressed on Vero host cells (Fig. 6C and D) . In vitro inhibition of E. intestinalis adherence and infection of cells by the addition of exogenous alpha 3 beta 1 or alpha 5 beta 1 integrins supports our hypothesis that integrins are involved in microsporidia adherence and infection and implicates these integrins as putative host cell receptors for E. intestinalis spores. Furthermore, because the observed experimental inhibition of spore adherence resulted in a correlating reduction in subsequent host cell infection, the data presented herein support our hypothesis that spore adherence is a critical element in microsporidia host cell infection.
DISCUSSION
For most pathogenic microbes, adherence is the first critical step in the infection process. Many viruses, bacteria and parasites adhere to the surface of mammalian cells by interacting with surface GAGs (chains attached to core proteins), ECM proteins, ECM-binding integrins or a combination of these. For example, Streptococcus and Staphylococcus bacteria directly interact with fibronectin, which then bridges to integrins allowing for bacteria entry into host cells (Cue et al. 2000; Borisova et al. 2013 ). This type of interaction not only allows for the initial invasion of host cells but also for the spread to neighboring cells and dissemination within the host (Patti et al. 1994; Finlay and Falkow 1997; Rostand and Esko 1997; Bartlett and Park 2010 ). While we have previously addressed the role of GAGs in the adherence to and infection of host cells by microsporidia (Hayman, Southern and Nash 2005) , the results presented herein suggest that integrins also play a role in microsporidia adherence and infection. All of the ECM protein ligands used in this study share the canonical integrin-binding amino acid sequence RGD (Hay 1991) . Interestingly, about 100 putative Encephalitozoon intestinalis proteins identified from database search analyses contained similar RGD motifs. Therefore, an RGD-containing peptide was evaluated as a potential inhibitor of spore adherence and infection. Preincubation of cells with this peptide sequence alone is sufficient to inhibit spore adherence and infection of host cells. However, these assays could not determine whether the ECM proteins and RGD peptide are inhibiting E. intestinalis adherence to host cells by binding integrins and preventing subsequent spore/integrin interactions or by a different, unknown mechanism. Nevertheless, it is possible that microsporidia may be adhering to host cells in a manner similar to that of the apicomplexan parasite Toxoplasma gondii, which interacts directly with laminin, and then interacts with integrins on the host cell to achieve entry into the cell (Furtado, Cao and Joiner 1992) . While it could be advantageous for microsporidia spores to enter host cells, infection does not occur without polar filament extrusion and the transfer of sporoplasm.
Using a combination of CSA and ECM proteins as inhibitors did not increase the level of inhibition of spore adherence above that of each alone, suggesting that sulfated GAGs and ECM proteins may act via a shared mechanism to inhibit E. intestinalis adherence and infection. There are many examples of pathogens that interact with host cell GAG carbohydrates and ECM proteins. The bacterium Neisseria gonorrhoeae, for example, interacts with host cell heparan sulfate to facilitate the adherence to host cells, but it also interacts with the N-terminal end of the host cell fibronectin molecule, which allows an additional indirect interaction with the host cell alpha 5 beta 1 integrin via the fibronectin, resulting in uptake of the bacterium by the host cell (Van Putten, Duensing and Cole 1998).
To more directly examine host cell integrin involvement in microsporidia adherence and infection, we employed antibodies to integrin alpha and beta chains as potential inhibitors of E. intestinalis adherence to Vero host cells. Alpha 3, alpha 5, beta 1 and beta 2 antibodies inhibited spore adherence and subsequent host cell infection. These integrin chains were determined by alpha and beta integrin-mediated cell adhesion arrays to be expressed on the host cells used in our assays. While beta 1 chains can interact with 12 alpha chains, including alpha 3 and alpha 5, and are expressed on most cells in the body, beta 2 chains do not interact with alpha 3 or alpha 5 chains to form integrins, and are largely expressed on leukocytes, as opposed to epithelial cells (Hay 1991; Humphries, Byron and Humphries 2006; Barczyk, Carracedo and Gullberg 2010) . As a result, recombinant alpha 3 beta 1 and alpha 5 beta 1 human integrin proteins were used as inhibitors in the adherence/infection assays. Both alpha 3 beta 1 and alpha 5 beta 1 integrins significantly reduced spore adherence and infection to host cells by ∼60%, while the control alpha 6 beta 4 integrin had no effect, supporting our hypothesis that host cell integrins play a role in microsporidia adherence to and infection of host cells and suggesting that alpha 3 beta 1 and/or alpha 5 beta 1 may be host cell receptors or co-receptors for E. intestinalis spores. Because alpha 3 beta 1 and alpha 5 beta 1 integrins caused the same degree of inhibition in these assays, it is possible that the beta 1 integrin chain plays a more significant role in spore/host cell interactions rather than either alpha chain.
Alpha 3 beta 1 and alpha 5 beta 1 integrins are biologically relevant to microsporidiosis based on their broad expression in humans. These proteins are specifically expressed in the intestinal epithelium, the initial site of microsporidial infection and in other tissues to which the parasite may disseminate (Beaulieu 1992; Coburn et al. 1998; Kreidberg 2000; Salone et al. 2003; Behera et al. 2006; Barczyk, Carracedo and Gullberg 2010; Subbaram and Dipersio 2011; Lowell and Mayadas 2012) . Moreover, alpha 3 beta 1 and alpha 5 beta 1 integrins, along with the beta 1 integrin chain, are utilized directly or indirectly by a large variety of other pathogens for attachment and/or invasion of host cells (Salone et al. 2003; Wang et al. 2003; Hamzaoui et al. 2004; Eto et al. 2007; Stewart and Nemerow 2007; Reis and Horn 2010; Tjomsland et al. 2011) . Some microbes such as adenovirus and the bacterium Shigella bind directly to host cell integrins (alpha 3 beta 1 and alpha 5 beta 1, respectively) to gain access to host cells (Salone et al. 2003; Reis and Horn 2010) . Other pathogens, including members of the herpesvirus family, use the GAG heparan sulfate for initial cell adhesion, but require the interaction of alpha 3 beta 1 for entry into the cell (Wang et al. 2003; Stewart and Nemerow 2007) . This dual receptor mechanism of entry allows for the initial interaction to be comparatively nonspecific, while the second receptor interaction is one that is a more specific protein-protein interaction, which triggers a cellular response. This pathogen/host engagement mechanism is plausible for microsporidia given that both GAGs and integrins appear to play a role in adherence and infection.
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